OnKure Therapeutics Inc (OKUR)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$3.58+0.56%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · OKUR
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenues | 3.4 | 3.4 | 2.0 | 1.6 | — | — | — |
| Operating Expenses & Income | |||||||
| R&D Expenses | 47.0 | 48.3 | 43.8 | 32.1 | 37.7 | 28.2 | 15.9 |
| Operating Income | (62.1) | (63.0) | (54.4) | (36.9) | (53.8) | (39.8) | (19.6) |
| Earnings from Continuing Operations | |||||||
| EBT, Incl. Unusual Items | — | — | — | (77.4) | (52.0) | (39.8) | (19.5) |
| Income Tax Expense | — | 0.0 | — | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | |||||||
| Net Income | (58.7) | (59.5) | (52.7) | (35.3) | (52.0) | (39.8) | (19.5) |
| Per Share | |||||||
| Basic EPS | (1.18) | (4.40) | (15.28) | (124.41) | (2.12) | (2.19) | (9.60) |
| Diluted EPS | (1.18) | (4.40) | (15.28) | (124.41) | (2.12) | (2.19) | (9.60) |
| Revenue per Share | 0.07 | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 49.9 | 13.5 | 3.4 | 0.3 | 24.5 | 18.1 | 2.0 |
| Diluted Weighted Avg Shares | 49.9 | 13.5 | 3.4 | 0.3 | 24.5 | 18.1 | 2.0 |
| Supplemental | |||||||
| EBITDA | — | (62.5) | (53.9) | (36.5) | (53.8) | (39.8) | (19.5) |
| EBIT | (62.1) | (63.0) | (54.4) | (36.9) | (53.8) | (39.8) | (19.6) |
| Effective Tax Rate | — | — | — | 0.0% | 0.0% | 0.0% | 0.0% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.